logo
Delistings mount amid poor trading liquidity

Delistings mount amid poor trading liquidity

The Star05-05-2025
SINGAPORE: Four Singapore Exchange (SGX) companies announced privatisation offers last week, taking the number of companies that have received such offers in 2025 to at least 11.
While most of the companies received offers from major shareholders citing poor trading liquidity as the main reason for privatisation, one firm – gaming hardware distributor Ban Leong Technologies – received an offer last week from a third-party acquirer with no prior relationship to the company.
Singapore gaming company Epicsoft Asia, a wholly owned subsidiary of Nasdaq-listed gaming giant GCL Global, on April 30 made an offer to take Ban Leong private for 60.29 Singapore cents a share in cash.
The offer price represents a premium of 60.8% over Ban Leong's last transacted share price of 37.5 cents before the offer was made.
GCL Global's chief executive Sebastian Toke said that the company sees strong strategic value in acquiring Ban Leong, citing its distribution strength in South-East Asia and growth in commercial and eCommerce segments as qualities not fully reflected in its share price.
'Both Epicsoft Asia and Ban Leong are born and bred Singapore firms with a strong presence in interactive entertainment software and gaming-related hardware, respectively, in Asia,' Toke said.
'The acquisition would combine the strengths of both companies in ways that would enable GCL to expand its global strategy in developing and marketing differentiated gaming products.'
Epicsoft Asia has already received irrevocable undertakings to accept the offer from Ban Leong's managing director Ronald Teng Woo Boon and his wife Teo Su Ching, who together hold 28.13% of the company.
If Epicsoft Asia secures at least 90% of Ban Leong's issued shares at the close of its offer, it can compulsorily buy the remaining shares at the same offer price from shareholders who have not accepted the offer.
Shares of Ban Leong jumped by more than 57% to close the week at 59 cents, their highest level since the company listed in June 2005.
The proposed acquisition of Ban Leong underscores the disconnect between public market valuations on SGX and the underlying strengths of many listed companies.
Despite demonstrating strong performance and growth potential, firms like Ban Leong remain undervalued, largely due to low trading liquidity and limited market visibility.
This valuation gap is attracting buyers like GCL Global, who are willing to pay a premium for quality assets that the market has overlooked.
It also raises questions about how SGX can better support fairer valuations and stem the pace of delistings, which has been accelerating.
In 2025 so far, at least nine companies have announced potential delistings.
They are SLB Development, PEC, Econ Healthcare, Sinarmas Land, ICP, Amara Holdings, Procurri Corp, Aoxin Q&M and Ban Leong.
The privatisation offers for Amara, Procurri Corp, Aoxin Q&M and Ban Leong all took place last week.
Amara, which received an offer from its bosses and developers Wing Tai and Hwa Hong, has already secured irrevocable undertakings from chairman Albert Teo and his family, who collectively hold 90.58% of Amara.
Meanwhile, shareholders of Japfa and Paragon Real Estate Investment Trust have since accepted offers to be taken private. The companies will be delisted from the SGX.
In contrast, just one company, automotive group Vin's Holdings, has listed on the SGX so far. A second company, candy maker YLF Group Marketing, called off its planned initial public offering in April.
The pace of potential delistings also appears to be accelerating, compared with the previous year. In 2024, a total of 20 companies delisted from the Singapore bourse, while four new companies went public.
Two companies saw their shares dive last week, one of which was CapitaLand Investment (CLI), a constituent of the Straits Times Index (STI).
Shares of the property fund manager dropped 8% to S$2.53 on May 2 after trading ex-dividend.
This is the cut-off date when buying the stock no longer entitles investors to receive the next dividend payout.
CLI has declared a 2024 dividend of 12 cents a share, unchanged from 2023's payout, on May 13.
CLI on April 30 also announced poorer revenues for the first quarter of 2025 after excluding contributions from CapitaLand Ascott Trust (Clas) from its financial results.
Revenue amounted to S$496mil for the quarter ended March 31, representing a 24% year-on-year decline due to the deconsolidation of Clas.
In December 2024, CLI sold a 4.9% stake in Clas for S$162mil to an unrelated party, resulting in Clas no longer qualifying as its subsidiary.
Shares of iFast dropped by more than 11% during the week, closing on May 2 at S$6.30 despite announcing that its global trust, a Singapore-incorporated entity within the group, had been granted a trust business licence by the Monetary Authority of Singapore.
This will enable iFast to expand its wealth management capabilities by supporting clients across the entire wealth life cycle, from accumulation and growth to preservation and legacy planning, iFast said.
Still, the move failed to offset share price declines earlier in the week, when iFast on April 28 cut the 2025 profit before tax target for its Hong Kong operations to HK$380mil from its previous guidance of HK$500mil.
UOB, DBS Bank and OCBC Bank are scheduled to release their 2025 first quarter business updates on May 7, May 8 and May 9, respectively.
The three banks, which experienced price declines averaging 8% in April, now account for 51% of the STI.
Institutional investors sold over S$700mil worth of shares in the three banks in April, according to SGX data.
In contrast, retail investors ploughed S$1.58bil into the three stocks during the month, the data showed. — The Straits Times/ANN
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SGX Hits Record High As Broad Market Gains Fuel Weekly Rally
SGX Hits Record High As Broad Market Gains Fuel Weekly Rally

BusinessToday

time18 hours ago

  • BusinessToday

SGX Hits Record High As Broad Market Gains Fuel Weekly Rally

The Singapore stock market closed the week on a high note, with the Straits Times Index (STI) surging to a new all-time high amid strong gains across all major sectors. Investor sentiment remained upbeat, driven by institutional inflows, solid corporate fundamentals, and renewed interest in local IPOs. The STI advanced from approximately 4,130 at the start of the week to end July 18 at 4,161.43, notching a 2.8% weekly gain and rising 0.7% in the final trading session. During intraday trade, the index touched a record peak of 4,163.45, underscoring bullish momentum in Singapore equities. All 11 sectors on the Singapore Exchange (SGX) posted gains over the week, with Industrials (5.1%), Technology (4.7%) and Healthcare (4.6%) leading the charge. The financial sector also contributed to the rally, supported by steady performance from heavyweight banks and conglomerates. Top blue-chip performers included Jardine Matheson (1.3%), DBS (0.66%), OCBC (1.46%) and UOB (0.60%). Mid- and small-cap stocks also saw heightened activity and outsized gains, with names like Food Empire (6.6%), Seatrium (5.8%), Cortina (6.8%), Banyan Tree (8.7%) and Digilife (8.1%) among the standout movers. The strong performance was bolstered by ongoing institutional buying, with investors rotating into growth and cyclical names on expectations of improving regional economic activity. Optimism surrounding recent IPOs, particularly the successful listing of NTT DC REIT, also lifted market sentiment. Looking ahead, the market's broad-based rally and record-setting performance suggest strong underlying momentum, though analysts caution that valuations are becoming stretched. Focus will now shift to upcoming corporate earnings and macroeconomic data to gauge the sustainability of the rally. Related

S&P and Nasdaq finish on subdued note
S&P and Nasdaq finish on subdued note

The Star

time2 days ago

  • The Star

S&P and Nasdaq finish on subdued note

The S&P 500 lost 0.57 points, or 0.01%, to 6,296.79, and the Nasdaq gained 10.01 points, or 0.05%, to 20,895.66. The Dow fell 142.30 points, or 0.32%, to 44,342.19. NEW YORK: The S&P 500 and Nasdaq Composite ended little changed on Friday, overcoming a brief dip triggered by a Financial Times report indicating US President Donald Trump was pushing for steep new tariffs on European Union products. The FT report, which said the Trump administration was eyeing a minimum tariff of between 15% and 20% in any deal with the European bloc, sent markets lower before they partly recovered. Cancel anytime. Ad-free. Full access to Web and App. RM 13.90/month RM 9.73 /month Billed as RM 9.73 for the 1st month, RM 13.90 thereafter. RM 12.39/month RM 8.63 /month Billed as RM 103.60 for the 1st year, RM 148 thereafter.

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: MGRM, EPIX, BLBX, and PBBK
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: MGRM, EPIX, BLBX, and PBBK

Malaysian Reserve

time2 days ago

  • Malaysian Reserve

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: MGRM, EPIX, BLBX, and PBBK

NEW YORK, July 18, 2025 /PRNewswire/ — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the 'M&A Class Action Firm'), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Monogram Technologies Inc. (NASDAQ: MGRM) related to its sale to Zimmer Biomet Holdings, Inc. Under the terms of the proposed transaction, Monogram shareholders would receive an upfront payment of $4.04 per share in cash, and one non-tradeable contingent value right collectively worth up to $12.37 per share in cash payable (i) $1.04 upon completion of a proof-of-concept demonstration of Monogram's robotic system for unicompartmental (partial) knee arthroplasty made available to Zimmer's designated executives on or before the later January 31, 2026 or 30 days following the Closing; (ii) $1.08 upon the grant of 510(k) clearance by the FDA for Monogram's fully autonomous robotic system for use with Zimmer implants, as evidenced by formal clearance indicating substantial equivalence to a predicate device, on or before December 31, 2027; (iii) $3.41 when the company achieves gross revenue of at least $156 million between January 1, 2028 and December 31, 2028; (iv) $3.41 when the company achieves gross revenue of at least $381 million between January 1, 2029 and December 31, 2028; and (v) $3.43 when the company achieves gross revenue of at least $609 million between January 1, 2030 and December 31, 2030. Click here for more information It is free and there is no cost or obligation to you. ESSA Pharma Inc. (NASDAQ: EPIX) related to its sale to Xeno Acquisition Corp. Upon completion of the transaction, ESSA shareholders will receive a cash payment per share to be calculated based upon ESSA's cash balance at closing minus transaction costs, liability and legal exposure review, and a $4 million transaction fee payable to Xeno. Additionally, ESSA shareholders are entitled to receive one non-transferable contingent value right per share entitling them to future payments based on (i) up to $150,000.00, less any remaining liabilities and expenses not deducted at closing; and (ii) up to $2.8 million, less legal and other expenses incurred after closing. Click here for more information It is free and there is no cost or obligation to you. Blackboxstocks Inc. (NASDAQ: BLBX), relating to the proposed merger with REalloys Inc. Under the terms of the agreement, it is anticipated Blackbox's stockholders will own approximately 7.3% of the combined company's common stock. Click here for more information It is free and there is no cost or obligation to you. PB Bankshares Inc. (NASDAQ: PBBK) related to its sale to Norwood Financial Corp. Under the terms of the proposed transaction, PB Bankshares' shareholders will have the option to elect to receive either 0.7850 shares of Norwood common stock or $19.75 in cash for each common share of PB Bankshares they own. The election is subject to proration to ensure that, in the aggregate, 80% of the transaction consideration will be paid in the form of Norwood common stock. Click here for more information It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask: Do you file class actions and go to Court? When was the last time you recovered money for shareholders? What cases did you recover money in and how much? About Monteverde & Associates PC Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@ or by telephone at (212) 971-1341. Contact:Juan Monteverde, & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4740New York, NY 10118United States of Americajmonteverde@ (212) 971-1341 Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC ( Prior results do not guarantee a similar outcome with respect to any future matter.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store